Allergan

Allergan CEO Saunders lines up for $39M parachute after AbbVie buy
Allergan CEO Saunders lines up for $39M parachute after AbbVie buy
Fierce Pharma
Allergan
executive pay
Pharma CEOs
Brent Saunders
AbbVie
M&A
Flag link:
Table for two: AbbVie was Allergan's only suitor in $63B takeover that shocked the industry
Table for two: AbbVie was Allergan's only suitor in $63B takeover that shocked the industry
Fierce Pharma
AbbVie
Allergan
M&A
Flag link:
Whoops! Allergan's bid to shield Botox manufacturing secrets from competitors backfires
Whoops! Allergan's bid to shield Botox manufacturing secrets from competitors backfires
Fierce Pharma
Allergan
Botox
trade secrets
Flag link:
Allergan says it will shed two drugs as AbbVie takeover looms
Allergan says it will shed two drugs as AbbVie takeover looms
Pharmaforum
Allergan
brazikumab
Zenprep
AbbVie
M&A
Flag link:
AbbVie’s $63B Allergan buyout offer depends on Botox growth. But will it last?
AbbVie’s $63B Allergan buyout offer depends on Botox growth. But will it last?
Fierce Pharma
Allergan
AbbVie
Botox
M&A
Flag link:
Allergan beats profit, raises revenue forecast on Restasis, Juvederm demand
Allergan beats profit, raises revenue forecast on Restasis, Juvederm demand
Yahoo/Reuters
Allergan
earnings
Flag link:
Editas, Allergan launch first in vivo study of CRISPR-based medicine
Editas, Allergan launch first in vivo study of CRISPR-based medicine
BioPharma Dive
Editas Medicine
Allergan
clinical trials
CRISPR
EDIT-101
Flag link:
Among recent megamergers only AbbVie-Allergan looks like a winner: analyst
Among recent megamergers only AbbVie-Allergan looks like a winner: analyst
Fierce Pharma
AbbVie
Allergan
M&A
diversification
Flag link:
Allergan Pulls Textured Breast Implant Following FDA Request
Allergan Pulls Textured Breast Implant Following FDA Request
RAPS.org
Allergan
FDA
product recalls
breast implants
Biocell
Flag link:
AbbVie's Acquisitions Report Card Shows Investors Have a Reason to Worry About the Allergan Buyout
AbbVie's Acquisitions Report Card Shows Investors Have a Reason to Worry About the Allergan Buyout
Motley Fool
Amgen
Allergan
M&A
Flag link:
Roche doomsday is here: Long-feared Herceptin, Avastin biosims bust into U.S. market
Roche doomsday is here: Long-feared Herceptin, Avastin biosims bust into U.S. market
Fierce Pharma
Herceptin
Avastin
Roche
biosimilars
Allergan
Amgen
Flag link:
Why AbbVie's Stock Sank in the First Half of 2019
Why AbbVie's Stock Sank in the First Half of 2019
Motley Fool
AbbVie
Humira
biosimilars
M&A
Allergan
Flag link:
Are AbbVie and Allergan Really Better Together?
Are AbbVie and Allergan Really Better Together?
Motley Fool
AbbVie
Allergan
M&A
Flag link:
AbbVie deal for Allergan not about the taxes thanks to 2017 law
AbbVie deal for Allergan not about the taxes thanks to 2017 law
Biopharma Dive
Allergan
AbbVie
M&A
taxes
Flag link:
5 reasons AbbVie bought Allergan, and why they may not be enough
5 reasons AbbVie bought Allergan, and why they may not be enough
Biopharma Dive
AbbVie
Allergan
M&A
Humira
Botox
cash
diversification
Flag link:
Top analyst finds a silver lining in AbbVie’s $63B Allergan buyout — but there’s a catch
Top analyst finds a silver lining in AbbVie’s $63B Allergan buyout — but there’s a catch
Endpoints
AbbVie
Allergan
M&A
R&D
layoffs
Flag link:
Here's Why Nobody's Happy About This $63 Billion Buyout
Here's Why Nobody's Happy About This $63 Billion Buyout
Motley Fool
AbbVie
Allergan
M&A
Flag link:
How Brent Saunders’ Allergan experiment failed
How Brent Saunders’ Allergan experiment failed
Stat
Brent Saunders
Allergan
AbbVie
Pharma CEOs
Flag link:
AbbVie’s $63 Billion Mistake
AbbVie’s $63 Billion Mistake
Motley Fool
AbbVie
Allergan
M&A
Flag link:
AbbVie to acquire Allergan for $63 billion in megamerger of pharma giants
AbbVie to acquire Allergan for $63 billion in megamerger of pharma giants
Stat
AbbVie
Allergan
M&A
Humira
Flag link:

Pages